HomeCompareNUVA vs EPRT

NUVA vs EPRT: Dividend Comparison 2026

NUVA yields 5.03% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $36.5K in total portfolio value
10 years
NUVA
NUVA
● Live price
5.03%
Share price
$39.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$694.15
Full NUVA calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — NUVA vs EPRT

📍 EPRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUVAEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUVA + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUVA pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUVA
Annual income on $10K today (after 15% tax)
$427.67/yr
After 10yr DRIP, annual income (after tax)
$590.03/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, EPRT beats the other by $10,605.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUVA + EPRT for your $10,000?

NUVA: 50%EPRT: 50%
100% EPRT50/50100% NUVA
Portfolio after 10yr
$46.1K
Annual income
$6,932.51/yr
Blended yield
15.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

NUVA
Analyst Ratings
13
Buy
21
Hold
1
Sell
Consensus: Hold
Price Target
$58.00
+45.9% upside vs current
Range: $50.00 — $64.00
Altman Z
1.9
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUVA buys
0
EPRT buys
0
No recent congressional trades found for NUVA or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUVAEPRT
Forward yield5.03%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$27.8K$64.3K
Annual income after 10y$694.15$13,170.85
Total dividends collected$6.0K$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$58.00$35.50

Year-by-year: NUVA vs EPRT ($10,000, DRIP)

YearNUVA PortfolioNUVA Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$11,203$503.14$11,212$512.01$9.00EPRT
2$12,514$526.80$12,689$692.09$175.00EPRT
3$13,940$549.96$14,521$944.30$581.00EPRT
4$15,488$572.54$16,841$1,302.88$1.4KEPRT
5$17,167$594.52$19,841$1,821.64$2.7KEPRT
6$18,985$615.85$23,818$2,587.47$4.8KEPRT
7$20,950$636.49$29,230$3,744.65$8.3KEPRT
8$23,073$656.44$36,816$5,540.38$13.7KEPRT
9$25,364$675.66$47,806$8,413.17$22.4KEPRT
10$27,834$694.15$64,324$13,170.85$36.5KEPRT

NUVA vs EPRT: Complete Analysis 2026

NUVAStock

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Full NUVA Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this NUVA vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUVA vs SCHDNUVA vs JEPINUVA vs ONUVA vs KONUVA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.